PPD, also known as Pharmaceutical Product Development, is a global contract research organization (CRO) based in the United States. The company provides a range of services to pharmaceutical, biotechnology, and medical device industries, assisting them in drug development and clinical trials. Founded in 1985 in Wilmington, North Carolina, PPD has grown to become one of the leaders in the CRO industry.

Its headquarters are located in Wilmington, where the company started as a small research laboratory. Over the years, PPD has expanded its operations worldwide, establishing offices in more than 40 countries, including key locations in Europe, Asia, and Latin America. This global presence allows PPD to offer its services to clients all over the world.

PPD's main products and services include drug development, clinical research, laboratory services, and consulting. The company assists clients in all phases of drug development, from preclinical research to post-marketing studies. PPD's clinical research services include study design, patient recruitment, data management, and regulatory support.

The company also offers laboratory services such as bioanalytical testing and biomarker analysis. In terms of its market position, PPD ranks among the top CROs globally. It has a competitive standing in the industry, competing with other major players like IQVIA and Covance.

PPD's global sales have consistently grown, and it has built a strong reputation for its expertise, quality, and reliability in delivering clinical research services. Over the years, PPD has achieved several significant milestones and strategic changes. In 2019, the company went public with an initial public offering (IPO), further solidifying its position in the market.

Additionally, PPD has made key acquisitions and formed partnerships to expand its portfolio and capabilities. Notably, in 2020, PPD acquired Evidera, a leading provider of health economics and outcomes research services. As of the latest updates, PPD continues to thrive in the CRO industry.

The company remains committed to innovation and advancing drug development by leveraging its global network and expertise. PPD's strong financial performance and industry recognition position it well for future growth and success